Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmacielo Ltd PCLOF


Primary Symbol: V.PCLO

PharmaCielo Ltd. is a Canada-based global company with a focus on ethical and sustainable cultivating, processing and supply of all natural, pharmaceutical-grade medical dried cannabis flower and cannabis products to large channel distributors. The Company has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all-natural cannabis into standardized, medicinal-grade dried cannabis flower, cannabis oil extracts and cannabis related products sold in bulk to pharmaceutical companies and medicinal cannabis distributors globally. In Colombia, PharmaCielo Colombia is a fully licensed cultivator, producer, and distributor of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis extracts. Ubiquo is a knowledge management and medical consultation system that aims to create access to healthcare for Colombians.


TSXV:PCLO - Post by User

Post by Betteryear2on Feb 04, 2022 7:54am
230 Views
Post# 34396532

PharmaCielo Provides Update

PharmaCielo Provides Update
  • PharmaCielo is actively working with, and has recently shipped product to, established companies in ArgentinaBrazilColombia and Paraguay.
  • The Company's sales and technical teams are providing support to these customers as they conduct testing and advance product registrations using PharmaCielo APIsi, to market.

TORONTO and RIONEGRO, Colombia, Feb. 4, 2022 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. ("Holdings"), today provided investors with an update on its Latin American sales progress and its non-brokered private placement of debenture units.

<< Previous
Bullboard Posts
Next >>